期刊文献+

肺炎链球菌HMG-CoA合成酶基因克隆和表达

Cloning and expression of the mvaS from Streptococcus pneumoniae
下载PDF
导出
摘要 目的克隆、表达肺炎链球菌3-羟基-3-甲基戊二酰辅酶A合成酶(3-hydroxy-3-methylglutaryl-coenzyme Asynthase,HMGS)。方法采用基因工程技术克隆肺炎链球菌HMGS基因,对T226进行反突变,构建重组表达载体pET-HMGSm并表达HMGS。结果序列分析表明该基因与文献中报道的肺炎链球菌HMGS基因(No.AF290098)相比较有98.5%的同源性,存在18个核苷酸的差异,其中有2个核苷酸的不同导致编码的氨基酸改变,分别是Asn259→Ser,Ala349→Val,该基因编码蛋白由398个氨基酸组成。结论优化重组HMGS表达条件,在18℃0.4 mmol/L IPTG诱导表达4 h,用Ni-NTA层析柱分离纯化得到46 kDa特异性蛋白。 Objective To clone and express 3-hydroxy-3-methylglutaryl-coenzyme A synthase(HMGS) from Streptococcus pneumoniae.Methods The mvaS was cloned from S.pneumoniae.The nucleotide mutated(A226→T) was amplified to conduct back mutation.The recombinant expression plasmid pET-HMGSm was constructed and expressed.Results In comparison with the mvaS sequence of S.pneumoniae published in NCBI(AF290098),there were 98.5% homology and 18 nucleotides had been changed,resulting in two changed amino acids(Asn259→Ser,Ala349→Val).The HMGS of S.pneumoniae consisted of 398 amino acid residues.Conclusion The recombinant plasmid pET-HMGSm was expressed with 0.4 mmol/L IPTG induction for 4 h at 18 ℃,the product analyzed by SDS-PAGE showed that a specific protein band appeared with a molecular weight about 46 kDa.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2010年第5期450-454,共5页 Journal of Harbin Medical University
基金 国家自然科学基金(30771429) 教育部博士点基金项目(20060511002) 重点基金项目(106116) 湖北省自然科学基金资助(2006ABA197)
关键词 肺炎链球菌 3-羟基-3-甲基戊二酰辅酶A合成酶 克隆 表达 Streptococcus pneumoniae 3-hydroxy-3-methylglutaryl-coenzyme A synthase cloning expression
  • 相关文献

参考文献7

  • 1张在亭(综述),刘恩梅(审校),刘岚(审校).肺炎链球菌耐药趋势及耐药机制研究进展[J].国际儿科学杂志,2007,34(1):40-42. 被引量:5
  • 2Rohmer M,Knani M,Simonin P,et al.Isoprenoid biosynthesis in bacteria:a novel pathway for the early steps leading to isopentenyl diphosphate[J].Biochem J,1993,295(Pt2):517-524.
  • 3Campobasso N,Patel M,Wilding IE,et al.Staphylococcus aureus 3-hydroxy-3-methylglutaryl-CoA synthase:crystal structure and mechanism[J].J Biol Chem,2004,279(43):44883-44888.
  • 4Steussy CN,Vartia AA,Burgner JW 2nd,et al.X-ray crystal structures of HMG-CoA synthase from enterococcus faecalis and a complex with its second substrate/inhibitor acetoacetyl-CoA[J].Biochemistry,2005,44(43):14256-14267.
  • 5Wilding EI,Kim DY,Bryant AP,et al.Essentiality,expression and characterization of the class Ⅱ 3-hydroxy-3-methylglutaryl coenzyme A reductase of Staphylococcus aureus[J].J Bacteriol,2000,182(18):5147-5152.
  • 6Misra I,Narasimhan C,Miziorko HM.Avian 3-hydroxy-3-methylglutaryl-CoA synthase.Characterization of a recombinant cholesterogenic isozyme and demonstration of the requirement for a sulfhydryl functionality in formation of the acetyl-enzyme reaction intermediate[J].J Biol Chem,1993,268(16):12129-12135.
  • 7Wilding EI,Brown JR,Bryant AP,et al.Identification,evolution,and essentiality of the mevalonate pathway for isopentenyl diphosphate biosynthesis in gram-positive cocci[J].J Bacteriol,2000,182(15):4319-4327.

二级参考文献19

  • 1赵根明,BLACK Steve,SHINEFIELD Henry,王传清,张颖华,林玉尊,姜庆五.儿童肺炎链球菌的血清型及对抗生素的耐药性[J].复旦学报(医学版),2004,31(4):387-390. 被引量:17
  • 2姚开虎,陆权,邓力,俞桑洁,张泓,邓秋莲,沈叙庄,杨永弘.2000—2002年北京、上海和广州儿童肺炎链球菌携带及抗生素耐药性监测[J].中华医学杂志,2005,85(28):1957-1961. 被引量:61
  • 3Song JH,Chang HH,Suh JY,et al.Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries:a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP)[J].J Antimicrob Chemother,2004,53(3):457-463.
  • 4Huebner RE,Wasas AD,Klugman KP,et al.Prevalence of nasopharyngeal antibiotic-resistant pneumococcal carriage in children attending private paediatric practices in Johannesburg[J].S Afr Med J,2000,90(11):1116-1121.
  • 5Edelstein PH.Pneumococcal resistance to macrolides,lincosamides,ketolides,and streptogramin B agents:molecular mechanisms and resistance phenotypes[J].Clin Infect Dis,2004,38(Suppl 4):S322-327.
  • 6Lynch Ⅲ JP,Martinez FJ.Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia[J].Clin Infect Dis,2002,34(Suppl 1):S27-46.
  • 7Doktor SZ,Shortridge VD,Beyer JM,et al.Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations[J].Diagn Microbiol Infect Dis,2004,49(1):47-52.
  • 8Farell DJ,Douthwaite S,Morrissey Ⅰ,et al.Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT1999-2000 study[J].Antimicrob Agents Chemther,2003,47(6):1T77-1783.
  • 9Jacobs MR,Felmingham D,Appelbaum PC,et al.The Alexander Project 1998-2000:susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents[J].J Antimicrob Chemother,2003,52(2):229-246.
  • 10Doem GV,Heilmann KP,Huynh HK,et al.Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000,including a comparison of resistance rates since 1994-1995[J].Antimicrob Agents Chemother,2001,45(6):1721-1729.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部